[1]
D. Hartanto, J. A. Nugraha, and T. I. Budhy, “Differences in Total S-RBD Antibody SARS-CoV-2 Post-vaccination mRNA-1273 3rd Dosage (Heterologous Prime Booster) with Post-prime Vaccination Inactivated Whole Virus Two Doses (Homologous) in Health Personnel Surabaya H2LC Clinic”, JBP, vol. 24, no. 2, pp. 107–114, Dec. 2022.